Application and Prospects of BCL-2 Inhibitors in Acute Myeloid Leukemia
Research into the molecular biology of acute myeloid leukemia (AML) has facilitated the identification of therapeutic targets and the development of corresponding molecularly targeted drugs. The advent of the BCL-2 inhibitor venetoclax (VEN) concludes 50 years of stagnant clinical progress in AML an...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Chinês |
| 出版事項: |
Magazine House of Cancer Research on Prevention and Treatment
2025-12-01
|
| シリーズ: | Zhongliu Fangzhi Yanjiu |
| 主題: | |
| オンライン･アクセス: | http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.25.0668 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|